PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BLFS vs. AVGO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BLFS and AVGO is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

BLFS vs. AVGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioLife Solutions, Inc. (BLFS) and Broadcom Inc. (AVGO). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%SeptemberOctoberNovemberDecember2025February
8.59%
38.80%
BLFS
AVGO

Key characteristics

Sharpe Ratio

BLFS:

1.03

AVGO:

1.46

Sortino Ratio

BLFS:

1.70

AVGO:

2.18

Omega Ratio

BLFS:

1.20

AVGO:

1.30

Calmar Ratio

BLFS:

0.54

AVGO:

3.30

Martin Ratio

BLFS:

6.95

AVGO:

9.00

Ulcer Index

BLFS:

7.70%

AVGO:

9.25%

Daily Std Dev

BLFS:

51.95%

AVGO:

56.91%

Max Drawdown

BLFS:

-99.98%

AVGO:

-48.30%

Current Drawdown

BLFS:

-97.97%

AVGO:

-8.26%

Fundamentals

Market Cap

BLFS:

$1.30B

AVGO:

$1.07T

EPS

BLFS:

-$1.11

AVGO:

$1.28

PEG Ratio

BLFS:

65.38

AVGO:

0.65

Total Revenue (TTM)

BLFS:

$90.63M

AVGO:

$39.61B

Gross Profit (TTM)

BLFS:

$48.35M

AVGO:

$24.36B

EBITDA (TTM)

BLFS:

-$11.13M

AVGO:

$19.21B

Returns By Period

In the year-to-date period, BLFS achieves a 7.59% return, which is significantly higher than AVGO's -1.34% return. Over the past 10 years, BLFS has underperformed AVGO with an annualized return of 29.32%, while AVGO has yielded a comparatively higher 38.84% annualized return.


BLFS

YTD

7.59%

1M

6.85%

6M

8.59%

1Y

58.78%

5Y*

12.36%

10Y*

29.32%

AVGO

YTD

-1.34%

1M

-3.67%

6M

38.80%

1Y

88.99%

5Y*

54.23%

10Y*

38.84%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BLFS vs. AVGO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLFS
The Risk-Adjusted Performance Rank of BLFS is 7575
Overall Rank
The Sharpe Ratio Rank of BLFS is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of BLFS is 7474
Sortino Ratio Rank
The Omega Ratio Rank of BLFS is 6969
Omega Ratio Rank
The Calmar Ratio Rank of BLFS is 6868
Calmar Ratio Rank
The Martin Ratio Rank of BLFS is 8686
Martin Ratio Rank

AVGO
The Risk-Adjusted Performance Rank of AVGO is 8787
Overall Rank
The Sharpe Ratio Rank of AVGO is 8686
Sharpe Ratio Rank
The Sortino Ratio Rank of AVGO is 8282
Sortino Ratio Rank
The Omega Ratio Rank of AVGO is 8282
Omega Ratio Rank
The Calmar Ratio Rank of AVGO is 9595
Calmar Ratio Rank
The Martin Ratio Rank of AVGO is 8989
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BLFS vs. AVGO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BioLife Solutions, Inc. (BLFS) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BLFS, currently valued at 1.03, compared to the broader market-2.000.002.001.031.46
The chart of Sortino ratio for BLFS, currently valued at 1.70, compared to the broader market-4.00-2.000.002.004.006.001.702.18
The chart of Omega ratio for BLFS, currently valued at 1.20, compared to the broader market0.501.001.502.001.201.30
The chart of Calmar ratio for BLFS, currently valued at 0.71, compared to the broader market0.002.004.006.000.713.30
The chart of Martin ratio for BLFS, currently valued at 6.95, compared to the broader market0.0010.0020.0030.006.959.00
BLFS
AVGO

The current BLFS Sharpe Ratio is 1.03, which is comparable to the AVGO Sharpe Ratio of 1.46. The chart below compares the historical Sharpe Ratios of BLFS and AVGO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
1.03
1.46
BLFS
AVGO

Dividends

BLFS vs. AVGO - Dividend Comparison

BLFS has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.95%.


TTM20242023202220212020201920182017201620152014
BLFS
BioLife Solutions, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AVGO
Broadcom Inc.
0.95%0.94%1.71%3.02%2.24%3.05%3.54%3.11%1.87%1.43%1.13%1.22%

Drawdowns

BLFS vs. AVGO - Drawdown Comparison

The maximum BLFS drawdown since its inception was -99.98%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for BLFS and AVGO. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-53.83%
-8.26%
BLFS
AVGO

Volatility

BLFS vs. AVGO - Volatility Comparison

The current volatility for BioLife Solutions, Inc. (BLFS) is 9.57%, while Broadcom Inc. (AVGO) has a volatility of 21.99%. This indicates that BLFS experiences smaller price fluctuations and is considered to be less risky than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025February
9.57%
21.99%
BLFS
AVGO

Financials

BLFS vs. AVGO - Financials Comparison

This section allows you to compare key financial metrics between BioLife Solutions, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab